CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Accumulated Deficit
Balance, beginning of period at Feb. 01, 2020	$ 76,955	$ 172,885	$ (95,930)
Balance, beginning of period (in shares) at Feb. 01, 2020		13,955,826
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	0
Employee stock purchases	35	$ 35
Employee stock purchases (in shares)		34,999
Restricted stock issued		32,341
Net share settlement of stock options and restricted stock	(8)	$ (8)
Net share settlement of stock options and restricted stock (in shares)		(8,663)
Stock-based compensation expense	$ 307	$ 307
Repurchase and retirement of common stock (in shares)	0
Net income (loss)	$ (7,438)		(7,438)
Balance, end of period at May. 02, 2020	$ 69,851	$ 173,219	(103,368)
Balance, end of period (in shares) at May. 02, 2020	14,014,503	14,014,503
Balance, beginning of period at Jan. 30, 2021	$ 94,922	$ 174,391	(79,469)
Balance, beginning of period (in shares) at Jan. 30, 2021	14,292,250	14,292,250
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	$ 52	$ 52
Exercise of stock options (in shares)		10,669
Restricted stock issued		30,087
Net share settlement of stock options and restricted stock	(257)	$ (257)
Net share settlement of stock options and restricted stock (in shares)		(11,339)
Stock-based compensation expense	232	$ 232
Repurchase and retirement of common stock	$ (1,356)		(1,356)
Repurchase and retirement of common stock (in shares)	(47,350)	(47,350)
Net income (loss)	$ 1,719		1,719
Balance, end of period at May. 01, 2021	$ 95,312	$ 174,418	$ (79,106)
Balance, end of period (in shares) at May. 01, 2021	14,274,317	14,274,317